| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/31/2013 | CN102370942B Traditional Chinese medicine composition for treating epilepsy |
| 07/31/2013 | CN102370671B Active fraction in lucid ganoderma fruiting body, extracting method, application thereof and preparation |
| 07/31/2013 | CN102335430B Compound pharmaceutical composition containing midazolam and neuro protective agent |
| 07/31/2013 | CN102327518B Traditional Chinese medicine for treating insomnia |
| 07/31/2013 | CN102210663B Diarylalkanes as potent inhibitors of binuclear enzymes |
| 07/31/2013 | CN102008374B Pearl-traditional Chinese medicine fiber cloth membrane with far infrared functions of skin care and health care and weaving method and applications thereof |
| 07/31/2013 | CN101920008B Preparation containing Abeta 40 polypeptide and aluminum adjuvant and method for purifying Abeta 40 polypeptide |
| 07/31/2013 | CN101896452B Carbon linked modulators of gamma-secretase |
| 07/31/2013 | CN101732461B Composition for improving brain function and/or treating encephalopathy |
| 07/31/2013 | CN101619033B Modafinil polymorphic forms |
| 07/31/2013 | CN101495112B Dietary or pharmaceutical compositions containing tricyclic diterpenes and derivatives thereof for the treatment of depression. |
| 07/31/2013 | CN101404995B Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 07/31/2013 | CN101124247B Antibodies directed against amyloid-beta peptide and uses thereof |
| 07/30/2013 | US8497283 Autotaxin inhibitors |
| 07/30/2013 | US8497271 Modulators of G protein-coupled receptor 88 |
| 07/30/2013 | US8497265 Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors |
| 07/30/2013 | CA2714700C Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/30/2013 | CA2704083C Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 07/30/2013 | CA2641453C Thiadiazole derivatives for the treatment of neuro degenerative diseases |
| 07/30/2013 | CA2583973C Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 07/30/2013 | CA2579720C A pharmaceutical composition for treating ataxia, multiple system atrophy or balance disorders |
| 07/30/2013 | CA2579121C Process for production of optically active amine derivatives |
| 07/30/2013 | CA2569530C Thienopyrazole derivative having pde 7 inhibitory activity |
| 07/30/2013 | CA2463158C Depot formulations of iloperidone and a star polymer |
| 07/30/2013 | CA2462886C Flashmelt oral dosage formulation |
| 07/30/2013 | CA2422774C Remedies for amyotrophic lateral sclerosis |
| 07/30/2013 | CA2420854C Slow release pharmaceutical preparation and method of administering of same |
| 07/30/2013 | CA2413754C Canine hepatocyte growth factor |
| 07/25/2013 | WO2013110080A1 Cylindrins as etiologic agents of amyloid diseases |
| 07/25/2013 | WO2013109521A1 Pyran-spirocyclic piperidine amides as modulators of ion channels |
| 07/25/2013 | WO2013109199A1 Effervescent pharmaceutical formulations comprising pregabalin and vitamin b12 |
| 07/25/2013 | WO2013109016A1 Novel use for melatonin |
| 07/25/2013 | WO2013108857A1 Heterocyclic amide derivative and pharmaceutical product containing same |
| 07/25/2013 | WO2013108837A1 Pyrazole derivative with tlr inhibiting properties |
| 07/25/2013 | WO2013108780A1 AMYLOID β-PROTEIN-SPECIFIC PRODUCTION-INHIBITING POLYPEPTIDE |
| 07/25/2013 | WO2013108760A1 Composition useful in treating pain or rheumatoid arthritis, method for treating pain or rheumatoid arthritis using same, composition for lowering cytokine concentration and method for lowering cytokine concentration using same |
| 07/25/2013 | WO2013108262A1 Synergistic combination for the treatment of diabetic neuropathy |
| 07/25/2013 | WO2013107910A1 Neurological therapies |
| 07/25/2013 | WO2013107862A1 NOVEL 2-AMINO-4,5,6,8-TETRAHYDROPYRAZOLO[3,4-b]THIAZOLO [4,5-d]AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS |
| 07/25/2013 | WO2013107856A1 Imidazole derivatives as pde10a enzyme inhibitors |
| 07/25/2013 | WO2013107761A1 Substituted triazoles and their use for treatment and/or prevention neurological and psychiatric disorders |
| 07/25/2013 | WO2013107441A1 Process for producing a solid pharmaceutical composition comprising the active ingredient rasagiline |
| 07/25/2013 | WO2013107427A1 Therapeutic compositions for intranasal administration of zolpidem |
| 07/25/2013 | WO2013107336A1 Therapeutic uses |
| 07/25/2013 | WO2013107236A1 Crystal form of (6s)-5-methyltetrahydrofolate salt and method for preparing same |
| 07/25/2013 | WO2013107206A1 Chinese herbal medicine composition for treating diabetic foot |
| 07/25/2013 | WO2013107164A1 Novel indoleamine-2, 3-dioxygenase inhibitor, preparation method therefor and uses thereof |
| 07/25/2013 | WO2013055687A3 R(+)-n-formyl-propargyl-aminoindan |
| 07/25/2013 | WO2013050987A9 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors |
| 07/25/2013 | WO2013040227A3 Therapeutic compounds |
| 07/25/2013 | WO2012111021A8 Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of alzheimer's disease |
| 07/25/2013 | US20130190403 Administration of intravenous ibuprofen to trauma patients |
| 07/25/2013 | US20130190400 Method for producing gamma-aminobutyric acid and food produced thereby |
| 07/25/2013 | US20130190350 Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto |
| 07/25/2013 | US20130189343 Transmucosal administration system for a pharmaceutical drug |
| 07/25/2013 | US20130189314 Enteric-coated ht-2157 compositions and methods of their use |
| 07/25/2013 | US20130189219 N-terminally chemically modified protein compositions and methods |
| 07/25/2013 | CA2863343A1 Pyran-spirocyclic piperidine amides as modulators of ion channels |
| 07/24/2013 | EP2617717A1 P2x4 receptor antagonist |
| 07/24/2013 | EP2617715A1 Glycine transporter inhibitor |
| 07/24/2013 | EP2617713A1 New Pharmaceutical Compounds |
| 07/24/2013 | EP2617704A1 Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors |
| 07/24/2013 | EP2617433A2 Treatment of neurodegenerative diseases by targeting mirna |
| 07/24/2013 | EP2617432A1 Brain function enhancement composition and method for enhancing brain function |
| 07/24/2013 | EP2617430A1 Composition for improving brain function and method for improving brain function |
| 07/24/2013 | EP2617424A2 Derivatives of uric and thiouric acid for oxidative stress-related diseases |
| 07/24/2013 | EP2617420A1 Phenoxymethyl heterocyclic compounds |
| 07/24/2013 | EP2617418A1 Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 07/24/2013 | EP2617417A1 Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 07/24/2013 | EP2616485A2 Step-derived peptide for brain injury treatment |
| 07/24/2013 | EP2616477A2 6-substituted demethyl-estradiol derivatives as er-beta agonists |
| 07/24/2013 | EP2616440A1 Arylosulfonamides for the treatment of cns diseases |
| 07/24/2013 | EP2616430A2 Novel phenoxyisobutyric acid compounds and methods for synthesis |
| 07/24/2013 | EP2616094A2 Treatment of penetrative injury to the brain |
| 07/24/2013 | EP2616075A1 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia |
| 07/24/2013 | EP2616056A1 Terpenoid analogues and uses thereof for treating neurological conditions |
| 07/24/2013 | EP2616055A1 Compositions for treating cancer treatment - related fatigue |
| 07/24/2013 | CN203075249U Paster capable of refreshing and restoring brain |
| 07/24/2013 | CN1980899B Quinazolinone derivatives as parp inhibitors |
| 07/24/2013 | CN1822845B Means for preventing and treating cellular death and their biological applications |
| 07/24/2013 | CN1795196B Use of amide in preparing compound agent for repairing corneal sensitivity |
| 07/24/2013 | CN103221411A A crystalline form of (R)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
| 07/24/2013 | CN103221404A Nitrogen heterocyclic compounds useful as PDE10 inhibitors |
| 07/24/2013 | CN103221402A Triazole derivatives and their use for neurological disorders |
| 07/24/2013 | CN103221396A Buguanide derivative compound |
| 07/24/2013 | CN103221043A Inhibitors of ERK for developmental disorders of neuronal connectivity |
| 07/24/2013 | CN103214577A Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof |
| 07/24/2013 | CN103214576A IL-17 receptor A antigen binding proteins |
| 07/24/2013 | CN103214555A Peptide inhibitors for mediating stress responses |
| 07/24/2013 | CN103214488A Quinolinone derivative, pharmaceutical composition by taking quinolinone derivative as active component and preparation method |
| 07/24/2013 | CN103214483A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 07/24/2013 | CN103214478A Pyridineoxopyridazine derivatives |
| 07/24/2013 | CN103214471A Novel compound |
| 07/24/2013 | CN103214464A Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 07/24/2013 | CN103214450A Modulators of atp-binding cassette transporters |
| 07/24/2013 | CN103214431A 2,3-dihydrobenzazapine*compound or its salt and its medical application |
| 07/24/2013 | CN103214427A Crystal form and application of R-pramipexole |
| 07/24/2013 | CN103214382A Meclofenoxate hydrochloride compound and pharmaceutical composition thereof |
| 07/24/2013 | CN103214376A Substituted 4-aminocyclohexane derivatives |
| 07/24/2013 | CN103212094A Oxygen-fluorine liposome microbubble and preparation method thereof |